Summit Therapeutics (SMMT) Other Non Operating Income (2019 - 2023)

Summit Therapeutics (SMMT) has 3 years of Other Non Operating Income data on file, last reported at $419000.0 in Q1 2023.

• Quarterly Other Non Operating Income changed N/A year-over-year to $419000.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $419000.0 (changed N/A YoY) and the FY2023 annual result came in at $419000.0, changed N/A from the prior year.
• Other Non Operating Income advanced to $419000.0 in Q1 2023, from $416000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $419000.0 in Q1 2023 to a low of -$75000.0 in Q3 2019.
• A 3-year average of $253333.3 and a median of $416000.0 in 2020 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 654.67% in 2020, down 654.67% in 2020.
• Tracing SMMT's Other Non Operating Income over 3 years: stood at -$75000.0 in 2019, then soared by 654.67% to $416000.0 in 2020, then rose by 0.72% to $419000.0 in 2023.
• The last three Other Non Operating Income figures came in at $419000.0 (Q1 2023), $416000.0 (Q3 2020), and -$75000.0 (Q3 2019), per Business Quant data.